First-in-Human Clinical Results Published in The Journal of Clinical Pharmacology and Presented at WCP2026 T-E Pharma’s subsidiary, Immunwork, Inc., announced […]
T-E Pharma is honored to be invited by the Journal of the Chinese Chemical Society (JCCS) to publish a review
Great news! The long-acting GLP-1 receptor agonist TE-8105 has achieved an innovative breakthrough in formulation development, successfully creating a more
Great news! Our latest publication presents TE-1146 as a novel therapeutic strategy for the treatment of multiple myeloma. We are
Great News! Immunwork’s Latest Publication Offers a Promising Clinical Solution for Diabetes, Obesity, and NASH Disease! The study, titled “2FA-Platform
Exciting news! Our latest published paper offers promising solutions for multiple myeloma treatment through ADC technology platform! We are thrilled
Exciting News! Immunwork’s Latest Published Paper Offers Promising Solutions for Pancreatic Cancer Treatment, Diagnostics, and Applications in ADC and ARC!
